Provided by Tiger Trade Technology Pte. Ltd.

ZYMEWORKS INC (US)

25.15
-0.8100-3.12%
Post-market: 25.150.00000.00%19:30 EDT
Volume:844.45K
Turnover:21.41M
Market Cap:1.78B
PE:-12.45
High:26.19
Open:26.18
Low:25.04
Close:25.96
52wk High:31.34
52wk Low:16.00
Shares:70.96M
Float Shares:66.63M
Volume Ratio:0.72
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0200
EPS(LYR):-1.0800
ROE:-72.31%
ROA:-24.14%
PB:22.21
PE(LYR):-23.29

Loading ...

Analysts Are Bullish on These Healthcare Stocks: Charles River Labs (CRL), Zymeworks (ZYME)

TIPRANKS
·
Aug 06

Zymeworks price target raised to $51 from $46 at H.C. Wainwright

TIPRANKS
·
Aug 06

Zymeworks Inc. Expected to Post a Loss of 46 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Zymeworks (ZYME) Receives a Buy from B. Riley Securities

TIPRANKS
·
Jul 30

Zymeworks to Report Q2 Results After Market Close

Reuters
·
Jul 16

Zymeworks price target raised to $31 from $28 at Truist

TIPRANKS
·
Jul 07

Zymeworks is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 07

Zymeworks Said to Near $929 Million Deal for Theravance - Bloomberg News

Reuters
·
Jul 03

Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX), Taysha Gene Therapies (TSHA) and Zymeworks (ZYME)

TIPRANKS
·
Jul 01

PRESS Digest-canada - June 30

Reuters
·
Jun 30

Analysts Are Bullish on Top Healthcare Stocks: BioCryst (BCRX), Zymeworks (ZYME)

TIPRANKS
·
Jun 30

Zymeworks, Inc. : Wells Fargo Raises Target Price to $37 from $34

THOMSON REUTERS
·
Jun 30

Zymeworks price target raised to $37 from $35 at Citi

TIPRANKS
·
Jun 30

Zymeworks Down 6.1%

THOMSON REUTERS
·
Jun 29

Zymeworks Posts Investor Presentation on Planned Theravance Biopharma Acquisition for Yupelri Cash Flows

Reuters
·
Jun 29

Deals of the Day-mergers and Acquisitions

Reuters
·
Jun 29

Why This Biotech Stock is Falling After a $929 Million Buyout Lifeline

Dow Jones
·
Jun 29

Theravance Biopharma: Co to Pay $32.5 Mln Termination Fee to Zymeworks, if Deal Terminated Under Certain Circumstances

THOMSON REUTERS
·
Jun 29

Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash

TIPRANKS
·
Jun 29

Theravance Biopharma Shares Fall 3.3% Premarket; Co to be Acquired by Zymeworks for $17 Per Share in Cash Plus a Contingent Value Right

THOMSON REUTERS
·
Jun 29